Heska Corporation engages in the discovery, development, manufacture, marketing, sale, distribution, and support of veterinary products in the United States. The company operates in two segments, Core Companion Animal Health (CCA); and Other Vaccines, Pharmaceuticals, and Products (OVP). The CCA segment offers diagnostic and monitoring instruments and supplies; single use diagnostic and point-of-care tests; vaccines; and pharmaceuticals, primarily for canine and feline use. The segment also offers various products, including electrolyte and blood gases instrument, blood chemistry instrument, and hematology instrument and their consumables. The OVP segment provides private label vaccine...